¡°	superior sublingual buprenorphine bioavailability	14.732099183516562
¡°	dissolve buprenorphine	13.353453427621298
¡°	buprenorphine effect	13.24150414174901
¡°	buprenorphine action	13.24125628070229
¡°	buprenorphine naloxone combination	12.048419229538906
¡°	partial agonist buprenorphine	11.18413037839645
	Suboxone sublingual tablet	10.46578499102773
	opioid addiction	9.720505720108873
	opioid dependence	8.873226101788749
	sublingual excipient	8.65931911155093
	sublingual administration	8.616701590123457
	sublingual treatment	8.575695450090796
	opioid receptor	7.446462889563512
	Suboxone tablet	7.132605905386815
	obvious citric acid carrier particle	6.507188843571465
	many opioid agonist	6.410570233020072
	generic sublingual tablet	6.173990802775777
	sublingual drug formulation	5.7960379331988845
	opioid craving	5.043249693396379
	opioid antagonist3	5.043249693396379
	Suboxone (r) tablet	4.789939475296225
	full opioid	4.755485369673294
	sublingual tablet formulation	4.687162177880781
	related sublingual product	4.283911926117623
	naloxone functional blockade	4.277487309292449
	enhanced opioid effect	3.6385625820010055
¡°	Zubsolv formulation	3.5178841262636698
¡°	Zubsolv product	3.440317108451177
	opioid base pharmaceutical product	2.859178674169077
	full agonist	2.483872027139037
	heroin	1.7289055472606492
	Subutex	1.7289055472606492
	agonist effectiveness	1.6745229903872787
	watersoluble carrier particle	1.5792844361461988
	wherein microparticle	1.2451516064166732
	poor transmucosal bioavailability	0.987748365056533
	large particle	0.7607579834262082
	small particle	0.7606176563029706
	optimum bioavailability	0.7349766863263502
	Allowability	0.6951944539145204
	Opioid Dependence	0.6818940775956411
	sodium citrate	0.6292980234026043
	cairn	0.5763018490868831
	substitution therapy tablet	0.5388016740156829
	many antagonist	0.5266480421621882
	Pharmaceutical Composition	0.5181566170838248
	cessation	0.4988938836427915
	dissolving	0.4988938836427915
	interactive mixture	0.48251382250314573
	instant tablet	0.4703797357486213
	tablet composition	0.46281624481414346
	pH	0.45660823936854406
	Acute Disorders	0.42333431865225474
	orally dissolvable film	0.4226403286324498
	oral film	0.3831413233759575
	croscarmellose sodium	0.3801057492536164
	substitution therapy formulation	0.33477058747870503
	less narcotic effect	0.2887390775079404
	substitution therapy present	0.2571692498870055
	lower dependency	0.25511408323773255
	two film	0.2534125356808738
	Physicians Desk Reference	0.2424910365711329
	effective substitution therapy dose	0.1720734468192287
	n.2	0.17200870120403614
	bioequivalent result	0.14433321654294287
	Treatment	0.14432584223964462
	pharmacologically effective amount	0.1398895141320535
	withdrawal symptom	0.125540059327524
	pain	0.10668056555365348
	Notice	0.09641425966994371
	high bind affinity	0.09093853905161975
	specific formulation	0.07763821173105988
	injection	0.07315557220415951
	pharmaceutically acceptable salt	0.07089908822528321
	pharmaceutically active substance	0.06796064648114451
	appropriate pharmacological amount	0.06273876158178411
	essentially formulation	0.05873825245881715
	homogeneous combination	0.0575671314676143
	wet granulation process	0.056304101821963694
	superior pharmacokinetic profile	0.05518402385811884
	inadequate dosage	0.049225742126545714
	clinical trial	0.04918069815328805
	therapeutically optimal balance	0.04899552942297426
	Example	0.046647577135406765
	Paragraph IV certification	0.046111750350180995
	Applicant	0.04392179876648982
	selection	0.04248845921642998
	Delaware	0.04231044932549435
	enhance therapeutic effect	0.038120634549742634
	improved treatment	0.03292895359802493
	unobvious improvement	0.03097063931126445
	ANDA	0.030126795576299676
	compliance	0.024625441479686573
	improved function	0.02348345984641006
	FDA	0.023305084662008216
	abbreviate drug application	0.020518643520108747
	little interference	0.01872520453981945
	improve treatment	0.018328403520633134
	Hatch Waxman litigation	0.017670360899491366
	Newman	0.014117886671553868
	Abbreviated New Drug Application	0.012710116073671765
	District Court Decision	0.012057937609178055
	abuse	0.01192264869882509
	ingredient	0.009661594350564285
	instant invention	0.009146324910660848
	Prior Art	0.008363059291817817
	contact	0.007257294437349617
	skilled artisan	0.00662757520339593
	manufacturing process	0.005758984075393012
	generic counter part	0.005613185508724155
	theory	0.0029001394328916205
	Examiner statement	0.0024390529486210256
	mere presence	0.0024081523937210425
	June	0.002361708619584101
	accordance	0.0022583768367237045
	property	0.0022583768367237045
	datum	0.002042074345297351
	structural characteristic	0.0018862215472198265
	bench trial	0.001761602732298499
	December	0.0014402826301466698
	value	0.0013146816718523921
	reduce amount	0.001283817243124518
	May	0.000969496871544854
	large number	0.0007176676345158572
	nature	0.0003977314878774805
	problem	0.0003912445633925232
	filing date	0.0003821477099233194
	continue need	0.0003510398834785211
	patentability	0.00033898003371155965
	clear convincing evidence	0.00032714758583006
	competitor filing	0.000269334586857981
	obviousness	0.00021529863589825563
	ordinary skill	8.389134992582367e-05
	background	8.298560459627657e-05
	invalidity	6.590974959802476e-05
	method	6.174792429036276e-05
	inventor	2.958789294077492e-05
	emphasis	1.4273118844507893e-05
	prosecution	6.999876901038482e-06
	patentee	4.11445289904533e-06
	reference	3.425718318048213e-06
	J.	1.321245888561099e-06
	party	3.3203130517215276e-08
	district court	5.500861237907967e-09
	judgment	3.3483362502792513e-09
	prior art	5.6514451597859555e-12
	Appeals	0.0
